This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Schering Corporation. Active years: 2000-2002.
Company Filing History:
Years Active: 2000-2002
Title: Jon E Silver: Innovator in Monoclonal Antibody Development
Introduction
Jon E Silver is a prominent inventor based in San Jose, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of humanized monoclonal antibodies. With a total of 2 patents, his work has the potential to impact therapeutic approaches for various diseases.
Latest Patents
Jon E Silver's latest patents focus on the design, cloning, and expression of humanized monoclonal antibodies against human interleukin-5. One of his notable inventions is a monoclonal antibody that specifically binds to human interleukin-5. This patent also includes a hybridoma that produces the monoclonal antibody, complementary DNAs encoding the heavy and light chain variable regions, and humanized monoclonal antibodies. Additionally, it encompasses pharmaceutical compositions that include the monoclonal antibody or anti-idiotypic antibodies directed against it, along with binding fragments and single-chain binding proteins derived from the antibody.
Career Highlights
Jon E Silver is associated with Schering Corporation, where he has been instrumental in advancing research in monoclonal antibodies. His innovative work has contributed to the understanding and application of these antibodies in therapeutic settings.
Collaborations
Throughout his career, Jon has collaborated with notable colleagues, including Chuan-Chu Chou and William T Windsor. These partnerships have further enhanced the research and development of monoclonal antibodies.
Conclusion
Jon E Silver's contributions to the field of biotechnology, particularly in the development of humanized monoclonal antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical therapies.